PT64907B - Procede de preparation d'une formulation a activite retarde - Google Patents
Procede de preparation d'une formulation a activite retardeInfo
- Publication number
- PT64907B PT64907B PT64907A PT6490776A PT64907B PT 64907 B PT64907 B PT 64907B PT 64907 A PT64907 A PT 64907A PT 6490776 A PT6490776 A PT 6490776A PT 64907 B PT64907 B PT 64907B
- Authority
- PT
- Portugal
- Prior art keywords
- preparing
- delayed activity
- activity formulation
- formulation
- delayed
- Prior art date
Links
- 230000003111 delayed effect Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55910775A | 1975-03-17 | 1975-03-17 | |
| US65800376A | 1976-02-13 | 1976-02-13 | |
| KR7600645A KR800001387B1 (en) | 1975-03-17 | 1976-03-16 | Process for preparing sustained release formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT64907A PT64907A (fr) | 1976-04-01 |
| PT64907B true PT64907B (fr) | 1978-03-24 |
Family
ID=27348140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT64907A PT64907B (fr) | 1975-03-17 | 1976-03-16 | Procede de preparation d'une formulation a activite retarde |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS51115910A (en:Method) |
| AR (1) | AR222624A1 (en:Method) |
| AT (1) | AT353415B (en:Method) |
| AU (1) | AU505355B2 (en:Method) |
| CA (1) | CA1073358A (en:Method) |
| CH (1) | CH630257A5 (en:Method) |
| DD (1) | DD124102A5 (en:Method) |
| DE (1) | DE2611041A1 (en:Method) |
| DK (1) | DK148344C (en:Method) |
| ES (1) | ES446075A1 (en:Method) |
| FR (1) | FR2304354A1 (en:Method) |
| GB (1) | GB1546448A (en:Method) |
| GR (1) | GR60341B (en:Method) |
| IE (1) | IE43083B1 (en:Method) |
| LU (1) | LU74558A1 (en:Method) |
| MC (1) | MC1101A1 (en:Method) |
| NL (1) | NL190313C (en:Method) |
| NZ (1) | NZ180321A (en:Method) |
| PH (1) | PH14927A (en:Method) |
| PT (1) | PT64907B (en:Method) |
| SE (1) | SE433804B (en:Method) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ197543A (en) * | 1980-07-02 | 1984-12-14 | Commw Scient Ind Res Org | Controlled release compositions for inclusion in intraruminal devices |
| CH649215A5 (de) * | 1981-04-29 | 1985-05-15 | Hoffmann La Roche | Pharmazeutische praeparate. |
| CH652025A5 (de) * | 1981-09-14 | 1985-10-31 | Hoffmann La Roche | Pharmazeutisches praeparat. |
| US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
| CH666406A5 (de) * | 1984-02-29 | 1988-07-29 | Sandoz Ag | Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten. |
| GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
| JPS61501511A (ja) * | 1984-03-21 | 1986-07-24 | アメリカン・ホ−ム・プロダクツ・コ−ポレイション | 徐放性医薬カプセル |
| JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
| HU195729B (en) * | 1985-02-05 | 1988-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides |
| GB8524135D0 (en) * | 1985-10-01 | 1985-11-06 | Sandoz Ltd | Darodipine compositions |
| NL194822C (nl) * | 1985-10-01 | 2003-04-03 | Novartis Ag | Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan. |
| US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
| US4814178A (en) * | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| IE64128B1 (en) * | 1990-02-26 | 1995-07-12 | Byrne Rynne Holdings Ltd | A pharmaceutical composition |
| DE69207656T2 (de) * | 1991-01-30 | 1996-10-17 | The Wellcome Foundation Ltd., London | Wasserlösliche tabletten |
| US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| EP0580861B1 (en) * | 1991-04-08 | 1998-09-09 | Nippon Shinyaku Company, Limited | Sustained release capsule for adhesion in the gastrointestinal tract |
| JPH07507059A (ja) * | 1992-03-25 | 1995-08-03 | デポムド システムズ，インコーポレイテッド | アルキル置換セルロースをベースとする持続放出性経口薬剤投与剤形 |
| US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| ES2144532T3 (es) * | 1993-10-29 | 2000-06-16 | Scherer Corp R P | Relleno de capsula de gelatina que puede formar espuma. |
| JPH09504286A (ja) * | 1993-10-29 | 1997-04-28 | レキット アンド コールマン プロダクツ リミテッド | 発泡しうるゼラチンカプセル充填物 |
| US5888540A (en) * | 1993-10-29 | 1999-03-30 | Sugden; Keith | Pharmaceutical products |
| NZ287277A (en) * | 1994-05-13 | 1998-05-27 | Smithkline Beecham Corp | Oral preparation containing calcium source within a hydrophilic polymer matrix for increasing calcium absorption in the stomach |
| CN1172429A (zh) * | 1994-12-01 | 1998-02-04 | 希博斯药物公司 | 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系 |
| FR2820318B1 (fr) * | 2001-02-08 | 2005-12-23 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu |
| FR2820319B3 (fr) * | 2001-02-08 | 2003-12-05 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu |
| EP1245227A1 (en) * | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
| FR2874325B1 (fr) * | 2004-08-19 | 2006-10-20 | Sanofi Synthelabo | Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1059624B (de) * | 1954-11-11 | 1959-06-18 | Dr Knut Jacobus Sundman | Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form |
| JPS5512411B2 (en:Method) * | 1974-03-12 | 1980-04-02 | ||
| DE2439538C3 (de) * | 1974-08-17 | 1980-07-17 | Ludwig Heumann & Co Gmbh, 8500 Nuernberg | Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe |
-
1976
- 1976-03-05 CH CH277676A patent/CH630257A5/de not_active IP Right Cessation
- 1976-03-11 IE IE508/76A patent/IE43083B1/en unknown
- 1976-03-15 NZ NZ180321A patent/NZ180321A/xx unknown
- 1976-03-15 GR GR50306A patent/GR60341B/el unknown
- 1976-03-15 FR FR7607363A patent/FR2304354A1/fr active Granted
- 1976-03-15 MC MC761182A patent/MC1101A1/xx unknown
- 1976-03-15 LU LU74558A patent/LU74558A1/xx unknown
- 1976-03-16 SE SE7603325A patent/SE433804B/xx not_active IP Right Cessation
- 1976-03-16 AT AT192276A patent/AT353415B/de not_active IP Right Cessation
- 1976-03-16 DE DE19762611041 patent/DE2611041A1/de active Granted
- 1976-03-16 GB GB10482/76A patent/GB1546448A/en not_active Expired
- 1976-03-16 JP JP51027758A patent/JPS51115910A/ja active Granted
- 1976-03-16 ES ES446075A patent/ES446075A1/es not_active Expired
- 1976-03-16 CA CA248,018A patent/CA1073358A/en not_active Expired
- 1976-03-16 PT PT64907A patent/PT64907B/pt unknown
- 1976-03-16 DK DK113676A patent/DK148344C/da not_active IP Right Cessation
- 1976-03-16 AU AU12049/76A patent/AU505355B2/en not_active Expired
- 1976-03-16 DD DD191877A patent/DD124102A5/xx unknown
- 1976-03-17 AR AR262597A patent/AR222624A1/es active
- 1976-03-17 NL NLAANVRAGE7602776,A patent/NL190313C/xx not_active IP Right Cessation
- 1976-03-29 PH PH18224A patent/PH14927A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LU74558A1 (en:Method) | 1977-09-27 |
| IE43083L (en) | 1976-09-17 |
| DD124102A5 (en:Method) | 1977-02-02 |
| NL7602776A (nl) | 1976-09-21 |
| JPS51115910A (en) | 1976-10-13 |
| AT353415B (de) | 1979-11-12 |
| PH14927A (en) | 1982-01-29 |
| AU1204976A (en) | 1977-09-22 |
| AU505355B2 (en) | 1979-11-15 |
| DK148344C (da) | 1985-11-04 |
| PT64907A (fr) | 1976-04-01 |
| DE2611041C2 (en:Method) | 1988-06-09 |
| IE43083B1 (en) | 1980-12-17 |
| DK148344B (da) | 1985-06-17 |
| GB1546448A (en) | 1979-05-23 |
| DE2611041A1 (de) | 1976-10-14 |
| CA1073358A (en) | 1980-03-11 |
| DK113676A (da) | 1976-09-18 |
| ATA192276A (de) | 1979-04-15 |
| JPS638084B2 (en:Method) | 1988-02-19 |
| NZ180321A (en) | 1978-06-20 |
| NL190313C (nl) | 1994-01-17 |
| MC1101A1 (fr) | 1977-02-04 |
| CH630257A5 (en) | 1982-06-15 |
| ES446075A1 (es) | 1977-09-16 |
| FR2304354A1 (fr) | 1976-10-15 |
| GR60341B (en) | 1978-05-17 |
| SE433804B (sv) | 1984-06-18 |
| NL190313B (nl) | 1993-08-16 |
| SE7603325L (sv) | 1976-09-18 |
| FR2304354B1 (en:Method) | 1979-04-27 |
| AR222624A1 (es) | 1981-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT64907A (fr) | Procede de preparation d'une formulation a activite retarde | |
| LU80084A1 (fr) | Procede de preparation d'oligoimides | |
| BE840117A (fr) | Procede de preparation d'hydroxybenzaldehydes | |
| FR2314916A1 (fr) | Procede de preparation d'urethannes aromatiques | |
| BE839787A (fr) | Procede de preparation d'isocyanates aliphatiques | |
| BE864265A (fr) | Procede de preparation d'acides alcoyl-carboxyliques superieurs | |
| FR2306199A1 (fr) | Procede de preparation d'urethannes aromatiques | |
| FR2309514A1 (fr) | Procede de preparation d'acetoacetyl-arylamides | |
| BE840452A (fr) | Procede de preparation d'alkyleneglycols | |
| FR2301516A1 (fr) | Procede de preparation d'esters cyaniques aromatiques | |
| LU79019A1 (fr) | Procede de preparation d'une composition pesticide a activite synergique | |
| BE842940A (fr) | Procede de preparation d'oxaphospholannes-1,2, | |
| FR2309542A1 (fr) | Procede de preparation d'acetoacetylamino-5 benzimidazolone | |
| BE843288A (fr) | Procede de preparation d'indoloquinolizines | |
| BE840354A (fr) | Procede de preparation d'agents therapeutiques | |
| FR2322848A1 (fr) | Procede de preparation d'un ester cyclopropane-carboxylique | |
| FR2334654A1 (fr) | Procede de preparation d'halogeno-nitrobenzenes | |
| FR2309521A1 (fr) | Procede de preparation d'esters alkylcarbamiques ou alcenylcarbamiques | |
| BE843910A (fr) | Procede de preparation de 2,5-dioxo-1-oxa-2-phospholanes | |
| FR2307781A1 (fr) | Procede de preparation d'acenaphtenes | |
| BE859970A (fr) | Procede de preparation d'acides 2-carbamoylphosphiniques n-substitues | |
| FR2322152B1 (fr) | Procede de preparation d'acides epoxyalkylphosphoniques | |
| FR2329642A1 (fr) | Procede de preparation d'un dihalogenovinyl-cyclo-propane-carboxylate | |
| BE843500A (fr) | Procede de preparation d'oxaphospholannes-1,2, | |
| FR2339594A1 (fr) | Procede de preparation d'acides naphtylaminosulfoniques |